pyrimidin-2-one beta-ribofuranoside and Brain Neoplasms

pyrimidin-2-one beta-ribofuranoside has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balajee, AS; Meador, JA; Ravanat, JL; Su, Y	1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Brain Neoplasms

Article	Year
DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine. Carcinogenesis, 2010, Volume: 31, Issue:2 Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Proliferation; Cytidine; DNA Adducts; DNA Methylation; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Glioblastoma; Humans; Promoter Regions, Genetic; Tumor Cells, Cultured	2010

Article

Year

DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.

Carcinogenesis, 2010, Volume: 31, Issue:2

Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Proliferation; Cytidine; DNA Adducts; DNA Methylation; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Glioblastoma; Humans; Promoter Regions, Genetic; Tumor Cells, Cultured

2010